Figure 1From: Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in VivoGrowth inhibiting effects of Celecoxib in MCF-7 cells (A) and MDA-MB-231 cells (B). Cell viability was determined by MTT method. This assay was performed in triplicate. Dose- and time-dependent inhibition of cell growth could be observed after 96 h (P<0.05, ANOVA analysis). *P<0.05, ** P<0.01 vs. 24 h; #P<0.05, ##P<0.01 vs.10 μmol/L celecoxib.Back to article page